Tagged: Lessons Learned from Novartis FCPA

Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)

Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)

The Novartis and Alcon FCPA enforcement action is chock full of interesting issues.  See Novartis DPA Here , Alcon DPA Here and SEC Novartis Order Here. At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China.  Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its...